Search
Search Constraints
You searched for: Author/Creator Vlk, AlexandraLimit your search
- 615.372 1
- Adjuvant -- E6020 -- Lipopolysaccharide -- Synthetic monophosphoryl lipid A -- Toll-like receptor 4 -- TRIF bias 1
- Vaccines -- Periodicals 1
- alum alhydrogel -- BAL bronchoalveolar lavage -- BALf bronchoalveolar lavage fluid -- CIBR Center for Innovative Biomedical Resources -- DE differentially expressed -- FDR false discovery rate -- Ft Francisella tularensis -- FtLVS Francisella tularensis Live Vaccine Strain -- FtSchu S4 Francisella tularensis Schu S4 Strain (BSL-3) -- h hours -- IC50 inhibitory concentration for 50% inhibition -- IFN interferon -- Ig immunoglobulin -- i.m. intramuscular -- i.n. intranasal -- i.p. intraperitoneal -- IPA Ingenuity® Pathway AnalysisTM -- IRF3 interferon regulatory factor 3 -- LPS lipopolysaccharide -- LVS-V Ft LVS-functionalized nanoparticles (catanionic surfactant vesicles (V)) -- MAP mitogen-activated protein -- MD2 myeloid differentiation 2 -- min minutes -- MPL monophosphoryl lipid A (here, referring to detoxified product of bacterial membranes) -- MyD88 myeloid differentiation primary response protein 88 -- NF-κB nuclear factor kappa B -- Ova ovalbumin -- PE phytoerythrin -- PEC peritoneal exudate cells -- RIN RNA integrity number -- SEM standard error of the means -- sMPL synthetic monophosphoryl lipid A -- TH1 T helper 1 -- TH2 T helper 2 -- Ticam1 TIR-domain containing adaptor molecule 1 (a.k.a. TRIF) -- TLR4 Toll-like receptor 4 -- TLRs Toll-like receptors -- TRAM TRIF-related adaptor molecule -- TRIF TIR-domain containing adaptor inducing interferon-β (a.k.a. Ticam1) -- V empty catanionic vesicles (nanoparticles) 1